Clinical trials - Press Releases

Date	Title	Company
16-Dec-2019	Novartis receives positive CHMP opinion for Beovu® (brolucizumab) for the treatment of wet AMD	Novartis
16-Dec-2019	GAEU´s clients winners at the premiere of the EIC Accelerator	GAEU Consulting AB
16-Dec-2019	V-Bio Ventures invests in Augustine Therapeutics, a VIB and KU Leuven spin-off to fight neuromuscular diseases	V-Bio Ventures
16-Dec-2019	Research Article Cites HemoVoid™ in Biomarker Study for Parkinson’s Disease	Biotech Support Group LLC
16-Dec-2019	Pfizer Receives Positive CHMP Opinion for VYNDAQEL® (tafamidis) for Use in Patients with Transthyretin Amyloid Cardiomyopathy, a Rare and Fatal Disease	Pfizer Ltd
16-Dec-2019	Clinerion and Pangaea partner to improve cancer patient lives.	Clinerion Ltd.
13-Dec-2019	CGT Catapult hosts second annual workshop to address digital challenges in adoption of advanced therapies by the NHS	Advanced Therapy Medicinal Products (ATMPs) are
13-Dec-2019	UKI2S, CATAPULT VENTURES AND JONATHAN MILNER INVEST £500K IN GENE MODULATION NEWCOMER PENCIL BIOSCIENCES	: UK Innovation & Science Seed Fund
13-Dec-2019	OXGENE™ announces year of continued growth and first licensing deals in Asia	OXGENE™
13-Dec-2019	All haemophilia A patients in Republic of Ireland get continued access to Sobi’s extended half-life factor replacement therapy	Sobi
13-Dec-2019	Emergex Completes First Step in the Development of a Vaccine Candidate Against Intracellular Bacterium and Bioterrorist Agent Francisella Tularensis	Emergex Vaccines Holding Limited
13-Dec-2019	NICE AND THE SMC HAVE PUBLISHED RECOMMENDATIONS ON SHIONOGI’S MULPLEO® (LUSUTROMBOPAG), APPROVING ITS USE FOR THE TREATMENT OF SEVERE THROMBOCYTOPENIA IN ADULT PATIENTS WITH CHRONIC LIVER DISEASE UNDERGOING INVASIVE PROCEDURES	Shionogi & Co., Ltd
13-Dec-2019	Almirall and Iktos announce research collaboration in Artificial Intelligence for new drug design	Almirall, S.A. (ALM)
13-Dec-2019	Moberg Pharma comments on the results of the North American Phase 3 study with MOB-015	Moberg Pharma AB
13-Dec-2019	Nordic Nanovector provides update on LYMRIT 37-05 Phase 1 DLBCL trial	Nordic Nanovector ASA
13-Dec-2019	PureTech Affiliate Akili Announces AKL-T03 Achieved Primary Endpoint, Improving Cognitive Impairments in Major Depressive Disorder Trial	PureTech Health plc
13-Dec-2019	Transgene Reports on the Combination Trial of TG4010, Chemotherapy and Nivolumab in Non-Small Cell Lung Cancer	Transgene
13-Dec-2019	ViiV Healthcare files submissions to the FDA and EMA for the first-ever dispersible formulation of dolutegravir (DTG) for children living with HIV	ViiV Healthcare
13-Dec-2019	Hansa Biopharma has agreed with the FDA on a regulatory path forward for imlifidase in kidney transplantation of highly sensitized patients in the U.S.	Hansa Biopharma
13-Dec-2019	Medication storage and dosage advice for parents	Valley Northern Limited